Table 1 Participant demographics and characteristics

From: Antibody affinity and cross-variant neutralization of SARS-CoV-2 Omicron BA.1, BA.2 and BA.3 following third mRNA vaccination

Participant demographics and vaccination type

Convalescent COVID-19 n(%)

Naïve n(%)

Significance p value

Sex

0.7786

Male

10 (32)

18 (35)

 

Female

21(68)

33 (65)

 

Age mean (range) in years

46 (22–65)

53 (30–81)

0.1979

2nd dose

0.6683

Pfizer

27 (87)

41 (82)

 

Moderna

4 (13)

9 (18)

 

3rd dose

0.6013

  

Pfizer

27 (87)

37 (74)

 

Vaccine Type 3rd dose, Moderna

4 (13)

13 (26)

 

BMI mean

31

27

0.3529

Ethnicity

0.7715

Not Hispanic or Latino

29 (94)

50 (100)

 

Hispanic or Latino

2 (6)

0 (0)

 

Race

0.7566

White

31 (100)

50 (100)

 

Black

0 (0)

0 (0)